Webinar 2024.01

Current status of PSMA-targeted imaging and therapy 

Date: March 26, 2024
Time: 18:00 (CET)
Speaker: Lena Unterrainer, Munich/Germany

Webinar 2024.02

PCCT – New Insights into Cardiac Imaging

Date: April 16, 2024
Time: 18:00 (CET)
Speaker: Isabelle Ayx (Munich, Germany)

Webinar 2024.10

Multimodal characterization of cachexia in patients with lung cancer

Date: October 24, 2024
Time: 18:00 (CET)
Speaker: Armin Frille (Leipzig, Germany)

Sectral CT in Oncology

Date: January 24, 2023
Time: 18:00 (CEST)
Speaker: Nils Große Hokamp (Cologne, Germany)

Description

The aim of this webinar is to review the basic principles of dual energy computed tomography (DECT) and the available technological approaches to DECT-imaging. Further, available reconstructions from DECT will be discussed with a particular focus towards their application in oncologic imaging.

In the course of this talk, fundamental concepts of spectral CT and image reconstruction will be reviewed. Followed by a case-based review on how which reconstruction can be used in daily operations with a particular scope on oncology. Based on recent studies, future directions and applications of spectral results in oncologic imaging will discussed. As any new technology has its limitations or drawbacks, possible obstacles for technological and diagnostic workflow will be referred. Last, a brief review on the most recent studies will try to give an outlook on current trends in DECT-applications in oncologic patients.

Concluding, the talk will provide guidance on the targeted deployment of spectral in oncologic imaging.

Learning Objectives

• To understand the basic principles and technological approaches to dual energy computed tomograph
• To become familiar with the different reconstructions that can be computed from a dual energy CT acquisition
• To understand how spectral reconstructions can or may impact reporting routine in oncologic imaging now and in future.

About the speaker: Dr. Nils Grosse Hokamp

PD Dr. Nils Grosse Hokamp, PhD, MBA is senior attending radiologist in the Institute for Diagnostic and Interventional Radiology and University Hospital Cologne. He also is appointed lecturer in Experimental Radiology and Radiology at the Medical Faculty of the University of Cologne. His clinical focus lies on abdominal and oncologic imaging and he serves as head of Computed Tomography Research. The University Hospital Cologne was among the first users of Spectral CT in clinical Routine starting May 2016 and based on his early hands-on experience he was invited fellow to Case Western Reserve University in Cleveland, OH, USA for 12 months. His research group now focuses on quantitative imaging biomarkers obtained from spectral detector computed tomography, in particular iodine maps. To date, Dr. Grosse Hokamp has authored and co-authored >100 publications related on Spectral CT.

Assessment of tumoral heterogeneity in imaging

Date: February 13, 2023
Time: 18:00 (CEST)
Speaker: Matthias Frölich (Mannheim, Germany)

Description

In this talk, we will explore the use of imaging techniques for assessing the heterogeneity of tumor lesions, not only in terms of size, shape, but also in terms of lesional texture and interlesional variation. We will examine imaging modalities as well as quantitative image analysis methods and discuss how they can be used to improve diagnosis and treatment planning for cancer patients.

First, the importance of tumoral heterogeneity in resistance to treatment will be discussed. Second, the motivation for addressing tumoral heterogeneity in imaging will be explained. Third, tools and methodology as well as published evidence will be described. Finally, its value proposition for radiologists in the context of the whole treatment process, including interventional treatments, will be examined.

Learning Objectives

• Summarize the concept of tumoral heterogeneity and its importance in oncologic treatment
• Understand the importance of assessing tumoral heterogeneity in imaging for accurate diagnosis and treatment planning for cancer patients.
• Describe the methodology for unraveling tumor heterogeneity in imaging
• Understand the value radiology can provide by quantifying tumor heterogeneity for patients and therapy planning

About the speaker: Dr. Matthias Frölich

• Clinician Scientist at Department of Radiology and Nuclear Medicine in University Medical Center Mannheim
• Head of Research Group: Quantitative Imaging Markers with focus on Computed Tomography

Hybrid Imaging in hematologic malignancies

Date: March 07, 2023
Time: 18:00 (CEST)
Speaker: Clemens Cyran (Munich, Germany)

Response Assessment in Lymphoma – The Role of Morphologic and Metabolic Imaging

Date: April 06, 2023
Time: 18:00 (CEST)
Speaker: Wolfgang Kunz (Munich, Germany)

Metabolic Imaging with MRI

Date: May 15, 2023
Time: 18:00 (CEST)
Speaker: Ferdia Gallagher (Cambridge, United Kingdom)

PET-CT in Infection and Inflammation

Date: June 19, 2023
Time: 18:00 (CEST)
Speakers: Sikandar Shaikh (Somajiguda, Indian)

Quo Vadis, Theranostics 

Date: September 09, 2023
Time: 18:00 (CEST)
Speakers: Jose L. Vercher Conejero (Barcelona, Spain)

Imaging and Biopsy Biomarkers to Promote Cancer Nanomedicine Clinical Translation 

Date: September 19, 2023
Time: 18:00 (CEST)
Speakers: Twan Lammers (Aachen, Germany)

FAPI PET imaging in uro-oncology 

Date: October 09, 2023
Time: 18:00 (CEST)
Speakers: Lena Unterrainer (Munich, Germany)

FAPI PET imaging in uro-oncology 

Date: October 09, 2023
Time: 18:00 (CEST)
Speakers: Lena Unterrainer (Munich, Germany)

Concepts for translation imaging with machine learning

Date: November 23, 2023
Time: 18:00 (CET)
Speakers: Salvador Guillermo Castaneda Vega

Economic aspects in hybrid-imaging

Date: December 11, 2023
Time: 18:00 (CET)
Speakers: Felix Gerhard Gassert (Munich, Germany)